# elbion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/elbion

- Industry: Pharmaceuticals
- Headquarters: Radebeul, Germany
- Website: www.elbion.com
- Total disclosed funding: $25M
- Latest round: Series A (Jan 10, 2005)
- Investors on record: 7

## About

Elbion GmbH is a domain brokerage service that specializes in selling premium domain names, enhancing branding for technology-focused businesses.Elbion GmbH operates as a domain brokerage service based in Radebeul, Germany. The company was acquired by Biotie Therapies in October 2008 for an undisclosed amount. It has engaged in a total of 3 deals, with the latest funding round being a USD 10.00 mn round involving investors such as Mitsubishi Corporation, TVM Capital Life Science, and Temasek Holdings. The founder's background is not specified; however, the company continues to focus on premium domain sales.Elbion.com operates primarily as a domain brokerage service, specializing in the sale of premium domain names aimed at enhancing branding for technology and innovation businesses. The flagship offering, the domain ELBION.COM, serves as a memorable online identity for tech-focused organizations. The service allows clients to purchase catchy and relevant domain names, addressing challenges related to brand recognition and online presence. Elbion.com caters to a diverse clientele, including startups, established businesses, and entrepreneurs seeking to strengthen their digital footprint, primarily targeting North American and European markets.Elbion.com generates revenue through the direct sale of domain names, especially premium listings. Customers can purchase domains through an immediate payment structure or payment plans, such as for the domain ELBION.COM, priced at USD 3,999, with an option for a down payment of USD 395.90 followed by monthly installments of USD 174 over 23 months. This model ensures accessibility for various clients, from individual entrepreneurs to larger corporations. Revenue is derived from these domain sales and potential additional services, such as logo creation, offered alongside domain purchases, enhancing the business model within the domain brokerage sector.Elbion GmbH's strategy for future growth includes the potential development of new domain-related products and services. The company is also exploring expansion into new geographic regions, although specific markets or timelines have not been disclosed. The recent funding round of USD 10.00 mn is expected to support these initiatives, enabling the company to enhance its offerings and market presence, reflecting its commitment to improve brand visibility for its clients.

## Funding rounds

- Series A, Jan 10, 2005, $25M — 3i, Burrill & Company, Idinvest Partners, Deutsche Venture Capital, Marubeni, BayTech Venture Capital, Quintiles Transnational Corporation

## Investors

- 3i (https://capitalatlas.ai/funds/3i) — Series A
- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series A
- Idinvest Partners (https://capitalatlas.ai/funds/idinvest-partners) — Series A
- Deutsche Venture Capital (https://capitalatlas.ai/funds/deutsche-venture-capital) — Series A
- Marubeni — Series A
- BayTech Venture Capital (https://capitalatlas.ai/funds/baytech-venture-capital) — Series A
- Quintiles Transnational Corporation — Series A